CSBR:NASDAQ
Champions Oncology Inc
4,59 US$
arrow_downward
-1,89%(-0,088) 1D
17 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,70 US$
High
4,70 US$
Low
4,59 US$
Mkt. cap
63,91 მლნ.
Avg. vol.
7,80 ათ.
Volume
4,85 ათ.
52-wk high
8,31 US$
52-wk low
4,52 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,70 US$
High
4,70 US$
Low
4,59 US$
Mkt. cap
63,91 მლნ.
Avg. vol.
7,80 ათ.
Volume
4,85 ათ.
52-wk high
8,31 US$
52-wk low
4,52 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
BigGo Finance
·
6 საათის წინ
New York Stocks Fall for Fourth Straight Session Ahead of Nvidia Earnings; Dow Plunges 1.6%
ChartMill
·
7 საათის წინ
S&P 500 After-Hours Gainers for Nov. 17, 2026
Fox Business
·
9 საათის წინ
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
·
4 საათის წინ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com